Jihoon Park

Executive Officer at Kaigene.

Raised on Kaigene filings

$55M

of $73.3M offered across 1 Form D filing

Form D filings: 1
Teammates: 3
Last filing: Oct 14, 2026

Company

Biotech · Rockville, MD

Antibody drugs that degrade disease-causing autoantibodies

Antibody drugs that degrade disease-causing autoantibodies

Investors: 22
Founded: 2021
Still open: $18.4M

Investors: 22
Sector: Biotech
Founded: 2021
HQ: Rockville, MD

Kaigene filings

Kaigene Form D filings
Filed	Security	Sold of offered	Filing
Oct 14, 2026	Equity	$55M/ $73.3M	Form D

EquityFiled Oct 14, 2026Form D
$55M/ $73.3M

Works with

Also named on Kaigene filings

Minjae ShinChief Executive Officer, Form D signerForm D signer Tae Heum JeongDirector Kyunghyun MinDirector